IL11 and neoplasm: By driving the expression of onco-immune modulatory genes, such as ENO1, MUC1, COL5A1, and IL11, FABP7 enhances tumor-associated immune suppression, particularly by facilitating the infiltration of immunosuppressive cell populations within TIME.